Hang Seng Bank (00011.HK) spent HK$61.09 million to repurchase 600,000 shares on April 25

Glonghui, April 25 | Hang Seng Bank (00011.HK) announced that it spent HK$61.109 million to repurchase 600,000 shares on April 25.

Gelonghui Finance07:45 ET

網易-S：2023年度報告

Futu News07:38 ET · Announcements

On April 25, BYD shares (01211.HK) spent 200 million yuan to buy back 960,000 A shares

Gelonghui, April 25 | BYD Co., Ltd. (01211.HK) issued an announcement. On April 25, 2024, the company spent 200 million yuan to repurchase 960,000 A shares at a repurchase price of 206.62-211.42 yuan per share

Gelonghui Finance06:20 ET

China Biopharmaceutical (01177.HK): Class 1 innovative drug “TQA3038 (siRNA)” completed phase I clinical research

Gelonghui, April 25 | China Biopharmaceutical (01177.HK) announced that the Group's self-developed Class 1 innovative drug “TQA3038 (siRNA)” has recently successfully completed phase I clinical research. TQA3038 injection is a small interfering RNA (siRNA) drug independently developed by the Group to target hepatitis B virus (HBV). The indication is chronic hepatitis B. As an N-acetylgalactosamine (GalNAc) -conjugated siRNA drug, TQA3038 can be concentrated in the liver to effectively degrade targeted RNA and inhibit translation of related proteins, thus

Gelonghui Finance06:06 ET

Sinopharm Holdings (01099): Sinopharm (000028.SZ) net profit of about 389 million yuan in the first quarter increased 7.33% year-on-year

Sinopharm Holdings (01099) announced Sinopharm's (000028.SZ) results for the first quarter of 2024, operating...

Zhitong Finance06:03 ET

國藥控股：公告 國藥一致截至2024年3月31日止第一季度之 主要未經審核會計數據和財務指標

Futu News06:00 ET · Announcements